Viewing Study NCT06331832


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-29 @ 1:30 PM
Study NCT ID: NCT06331832
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2024-03-26
First Post: 2024-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access of Imvotamab (IGM-2323) in Patients With R/R NHL
Sponsor: IGM Biosciences, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module